These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12423235)

  • 21. Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception.
    Jasmin L; Boudah A; Ohara PT
    J Comp Neurol; 2003 May; 460(1):38-55. PubMed ID: 12687695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling.
    Aasmundstad TA; Mørland J; Paulsen RE
    J Pharmacol Exp Ther; 1995 Oct; 275(1):435-41. PubMed ID: 7562582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracerebroventricular morphine produces antinociception by evoking gamma-aminobutyric acid release through activation of 5-hydroxytryptamine 3 receptors in the spinal cord.
    Kawamata T; Omote K; Toriyabe M; Kawamata M; Namiki A
    Anesthesiology; 2002 May; 96(5):1175-82. PubMed ID: 11981159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats.
    Malmberg AB; Yaksh TL
    Br J Pharmacol; 1995 Mar; 114(5):1069-75. PubMed ID: 7780642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability.
    Stain-Texier F; Boschi G; Sandouk P; Scherrmann JM
    Br J Pharmacol; 1999 Oct; 128(4):917-24. PubMed ID: 10556926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of P-glycoprotein modulation on the clinical pharmacokinetics and adverse effects of morphine.
    Drewe J; Ball HA; Beglinger C; Peng B; Kemmler A; Schächinger H; Haefeli WE
    Br J Clin Pharmacol; 2000 Sep; 50(3):237-46. PubMed ID: 10971308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats.
    Suzuki N; Kalso E; Rosenberg PH
    Eur J Pharmacol; 1993 Nov; 249(2):247-50. PubMed ID: 8287909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.
    Yang L; Fawcett JP; Zhang H; Tucker IG
    J Pharm Pharmacol; 2013 Apr; 65(4):561-6. PubMed ID: 23488785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat.
    Letrent SP; Pollack GM; Brouwer KR; Brouwer KL
    Pharm Res; 1998 Apr; 15(4):599-605. PubMed ID: 9587957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.
    Meineke I; Freudenthaler S; Hofmann U; Schaeffeler E; Mikus G; Schwab M; Prange HW; Gleiter CH; Brockmöller J
    Br J Clin Pharmacol; 2002 Dec; 54(6):592-603. PubMed ID: 12492606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?
    Lötsch J; Zimmermann M; Darimont J; Marx C; Dudziak R; Skarke C; Geisslinger G
    Anesthesiology; 2002 Oct; 97(4):814-9. PubMed ID: 12357145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.
    Abbott FV; Palmour RM
    Life Sci; 1988; 43(21):1685-95. PubMed ID: 2848167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine.
    Wu D; Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1997 Jun; 25(6):768-71. PubMed ID: 9193881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of selective COX-1 and -2 inhibition on formalin-evoked nociceptive behaviour and prostaglandin E(2) release in the spinal cord.
    Tegeder I; Niederberger E; Vetter G; Bräutigam L; Geisslinger G
    J Neurochem; 2001 Nov; 79(4):777-86. PubMed ID: 11723170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ketamine anesthesia on central nociceptive processing in the rat: a 2-deoxyglucose study.
    Porro CA; Cavazzuti M; Giuliani D; Vellani V; Lui F; Baraldi P
    Neuroscience; 2004; 125(2):485-94. PubMed ID: 15062990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine.
    Stuart-Harris R; Joel SP; McDonald P; Currow D; Slevin ML
    Br J Clin Pharmacol; 2000 Mar; 49(3):207-14. PubMed ID: 10718775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efavirenz does not interact with the ABCB1 transporter at the blood-brain barrier.
    Dirson G; Fernandez C; Hindlet P; Roux F; German-Fattal M; Gimenez F; Farinotti R
    Pharm Res; 2006 Jul; 23(7):1525-32. PubMed ID: 16779703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of morphine and its 3- and 6-glucuronide metabolites during morphine infusion in the sheep.
    Milne RW; Sloan PA; McLean CF; Mather LE; Nation RL; Runciman WB; Rutten AJ; Somogyi AA
    Drug Metab Dispos; 1993; 21(6):1151-6. PubMed ID: 7905398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphine metabolism, transport and brain disposition.
    De Gregori S; De Gregori M; Ranzani GN; Allegri M; Minella C; Regazzi M
    Metab Brain Dis; 2012 Mar; 27(1):1-5. PubMed ID: 22193538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The excitatory behavioral and antianalgesic pharmacology of normorphine-3-glucuronide after intracerebroventricular administration to rats.
    Smith GD; Smith MT
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1157-62. PubMed ID: 9618418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.